← Research index · Disorder page · Source YAML

Cross-provider research synthesis

Argininosuccinic Aciduria

MONDO:0008815 Curated 2026-07-04T00:00:00Z 9 harmonized findings

falcon · 34 citations openscientist · 46 citations

Concordant asserts the finding Partial supports a weaker/qualified form Contradictory conflicts with it Silent does not address it

Harmonized findings

Argininosuccinic aciduria is an autosomal recessive disorder of the enzyme argininosuccinate lyase (ASL), which cleaves argininosuccinate to arginine and fumarate; loss of ASL blocks the urea cycle, causing argininosuccinate accumulation, arginine deficiency, and hyperammonemia.

UNANIMOUS INTEGRATED

pathophysiologygenetic_factor

Provider	Stance	Score	Evidence
falcon	CONCORDANT	95%	ASL deficiency creates a block in ureagenesis, predisposing to hyperammonemia, and simultaneously disrupts arginine availability for nitric oxide (NO) production Falcon states the urea-cycle block and hyperammonemia driver mechanism directly. DOI:10.1126/scitranslmed.adh1334
openscientist	CONCORDANT	90%	ASL catalyzes step 4 of the urea cycle: argininosuccinate → arginine + fumarate. OpenScientist names the exact catalytic step lost, with the same downstream consequences.

ASL has a dual catalytic and structural role: beyond ureagenesis it scaffolds a multiprotein complex that channels arginine to nitric oxide synthase, so ASL loss produces a nitric-oxide deficiency causing endothelial dysfunction and a Mendelian form of endothelial-dependent hypertension.

UNANIMOUS INTEGRATED

pathophysiologygene_function

Provider	Stance	Score	Evidence
falcon	CONCORDANT	90%	ASL is described as required both for arginine synthesis and for channeling extracellular arginine to nitric oxide synthase (NOS), enabling tissue NO production Falcon describes the arginine-channeling-to-NOS role and links its loss to endothelial dysfunction and hypertension. DOI:10.1016/j.ajhg.2018.07.008
openscientist	CONCORDANT	95%	ASL serves as a structural scaffold for a multiprotein complex essential for channeling arginine to nitric oxide synthase (NOS) enzymes, thereby enabling nitric oxide (NO) production. OpenScientist gives the explicit structural-scaffold framing of the dual role and the NO-deficiency consequence.

A defining paradox of ASLD is that neurological, hepatic, and vascular complications occur independently of, and are disproportionate to, the frequency of hyperammonemic episodes — i.e., significant disease is ammonia-independent.

UNANIMOUS INTEGRATED

pathophysiologyphenotype

Provider	Stance	Score	Evidence
falcon	CONCORDANT	90%	provides a plausible route for neurocognitive disease that is decoupled from episodic hyperammonemia. Falcon frames neurocognitive disease as decoupled from hyperammonemia via the NO/BBB axis. DOI:10.1172/jci.insight.168475
openscientist	CONCORDANT	90%	that are disproportionate to and independent of the frequency of hyperammonemic episodes. OpenScientist states the same ammonia-independent paradox across neurological, hepatic, and vascular complications.

Chronic liver disease is a common component of ASLD, with elevated aminotransferases and a distinctive impairment of hepatic glycogen metabolism (excessive glycogen storage with reduced glycogen phosphorylase activity in the AslNeo/Neo mouse).

UNANIMOUS INTEGRATED

phenotypepathophysiology

Provider	Stance	Score	Evidence
falcon	CONCORDANT	90%	excessive hepatic glycogen accumulation and impaired glycogenolysis in AslNeo/Neo mice, with reduced glycogen phosphorylase protein/activity Falcon reports the impaired-glycogenolysis / reduced glycogen phosphorylase mechanism in the mouse model. DOI:10.1172/jci.insight.132342
openscientist	CONCORDANT	90%	excessive hepatic glycogen associated with impaired hepatic glycogenolysis and decreased glycogen phosphorylase activity OpenScientist independently reports the same hepatic glycogen / glycogen phosphorylase abnormality. PMID:31990680

Redox imbalance contributes to ASLD tissue injury, with loss of ASL driving increased oxidative stress; a more specific recent signature is glutathione depletion with altered upstream cysteine utilization.

MAJORITY INTEGRATED

pathophysiology

Provider	Stance	Score	Evidence
falcon	CONCORDANT	90%	dysregulation of glutathione biosynthesis and upstream cysteine utilization Falcon foregrounds the 2024 glutathione-depletion / cysteine-utilization signature as a distinct redox mechanism. DOI:10.1126/scitranslmed.adh1334
openscientist	PARTIAL	50%	Loss of ASL leads to increased oxidative stress, particularly in endothelial cells, contributing to vascular dysfunction OpenScientist asserts increased oxidative stress but frames it as endothelial/vascular; it does not report the specific glutathione-depletion / cysteine-utilization signature Falcon emphasizes. PMID:30075114

Neurological burden in ASLD emerges and worsens with age, with movement disorders becoming more prevalent over time — a late-emerging, partly ammonia-independent neurological trajectory.

MAJORITY INTEGRATED

phenotypeprognosis

Provider	Stance	Score	Evidence
falcon	CONCORDANT	90%	movement disorders become more prevalent with age Falcon reports the UK-cohort finding that movement disorders increase with age and are independent of hyperammonemia onset. DOI:10.1002/jimd.12691
openscientist	PARTIAL	50%	May decline with age; adults performed significantly less well than younger patients in some UCD studies OpenScientist supports age-related neurocognitive decline but does not specifically report the late-emerging movement-disorder phenotype Falcon quantifies. PMID:27215558

Trichorrhexis nodosa (brittle hair with nodular swellings) is a pathognomonic feature of ASLD attributable to arginine deficiency impairing structural (hair-keratin) protein synthesis.

SINGLE LEAD

phenotype

Provider	Stance	Score	Evidence
openscientist	CONCORDANT	90%	(brittle hair with nodular swellings) is a pathognomonic feature of ASA and results from arginine deficiency affecting structural protein synthesis in hair OpenScientist reports trichorrhexis nodosa as pathognomonic and mechanistically ties it to arginine deficiency. PMID:7141120
falcon	SILENT	—	Falcon's pathophysiology-focused report does not mention trichorrhexis nodosa or the hair phenotype at all.

Residual ASL enzymatic activity is a genotype-linked determinant of severity: individuals with ≤9% activity have more severe initial decompensations and more frequent hyperammonemic events.

MAJORITY LEAD

genetic_factorprognosis

Provider	Stance	Score	Evidence
openscientist	CONCORDANT	90%	Individuals with ≤9% of enzymatic activity had more severe initial decompensations and a higher annual frequency of HAEs than individuals above this threshold OpenScientist reports the quantitative ≤9%-activity genotype-phenotype severity threshold. PMID:31943503
falcon	PARTIAL	40%	genotype (c.1060C>T p.Q354X) associated with intractable seizures and psychomotor regression Falcon supports a genotype-severity link with a specific variant tied to intractable seizures, but does not report the enzymatic-activity threshold or hyperammonemic-event correlation. DOI:10.21203/rs.3.rs-3279667/v1

Emerging liver-directed disease-modifying therapies (LNP-delivered ASL mRNA, AAV8 gene transfer, and CRISPR base editing) rescue metabolic and survival phenotypes in preclinical ASLD models, though extrahepatic NO deficiency remains unaddressed.

UNANIMOUS LEAD

treatment

Provider	Stance	Score	Evidence
falcon	CONCORDANT	80%	lipid nanoparticle–delivered human ASL mRNA improves glutathione metabolism and chronic liver disease and rescues ASL-deficient mouse phenotypes while enhancing ureagenesis Falcon reports LNP-delivered ASL mRNA as a candidate disease-modifying therapy in the mouse model. DOI:10.1126/scitranslmed.adh1334
openscientist	CONCORDANT	80%	Intravenous injection into adolescent hypomorphic mice led to increased survival and body weight and correction of metabolites associated with the disease OpenScientist reports AAV8 gene therapy (plus CRISPR base editing elsewhere) as preclinical disease-modifying approaches, a different platform reaching the same conclusion. PMID:30253962, PMID:38579669

Narrative

Overview

Both providers frame argininosuccinic aciduria (ASLD) as an autosomal recessive urea-cycle disorder caused by argininosuccinate lyase deficiency, and both go beyond simple hyperammonemia to emphasize ASL's dual catalytic and structural role, the resulting nitric-oxide deficiency, and a multisystem, partly ammonia-independent phenotype (liver disease, hypertension, chronic neurological burden). Falcon is a pathophysiology-focused report anchored on recent (2018-2024) mechanistic primary literature; OpenScientist is a broad, 15-domain report adding clinical, genetic, diagnostic, epidemiological, and therapeutic breadth.

Agreement

The two reports converge strongly on the core biology: the ASL-catalyzed urea-cycle step and its loss driving argininosuccinate accumulation, arginine deficiency, and hyperammonemia; the dual catalytic/structural role of ASL in scaffolding the NOS complex and the consequent NO deficiency with endothelial-dependent hypertension; the ammonia-independent paradox in which neurological, hepatic, and vascular disease is disproportionate to hyperammonemic episodes; chronic liver disease with a characteristic impairment of hepatic glycogen metabolism (reduced glycogen phosphorylase in the AslNeo/Neo mouse); increased oxidative stress; and preclinical liver-directed disease-modifying gene/RNA therapies.

Divergence

Divergence is mostly coverage and emphasis rather than contradiction. Falcon uniquely foregrounds the 2024 glutathione-depletion / cysteine-utilization redox signature and the late-emerging, age-associated movement-disorder phenotype from the UK cohort. OpenScientist uniquely supplies the pathognomonic trichorrhexis nodosa phenotype, the quantitative ≤9%-enzymatic-activity genotype-phenotype severity threshold, intragenic complementation, epidemiology (second most common UCD, ~1 in 70,000), diagnostics, and a broader therapeutic catalog (AAV8, CRISPR base editing, liver transplantation). Where both touch a claim they agree; the partial stances reflect one provider carrying a more specific or quantitative form than the other. No direct contradictions were identified.

Integration

The core mechanistic findings (urea-cycle block and hyperammonemia, dual ASL/NO role and endothelial-dependent hypertension, the ammonia-independent paradox, chronic liver disease with impaired glycogen metabolism, oxidative stress, and the age-related neurological trajectory) are strong two-source or Falcon-anchored claims suitable for integration into the disorder YAML's pathophysiology and phenotype blocks.

Not integrated (leads)

Trichorrhexis nodosa, the ≤9%-activity genotype-phenotype threshold, and the emerging gene/RNA/base-editing therapies are retained as single-strong-provider leads pending PMID verification and fit against existing curated nodes rather than promoted directly; OpenScientist's epidemiology, diagnostics, and differential-diagnosis breadth are likewise curation leads.

Cross-provider synthesis comparing the falcon (pathophysiology-focused) and openscientist (comprehensive 15-domain) deep-research reports. best_matching_text values are verbatim excerpts from the cited report files; per-provider citations reflect the source each report leaned on and were not independently fetch-reference verified in this artifact. No direct contradictions were found; divergence is coverage/emphasis plus provider-specific quantitative detail.